Copyright
        ©The Author(s) 2002.
    
    
        World J Gastroenterol. Dec 15, 2002; 8(6): 1077-1080
Published online Dec 15, 2002. doi: 10.3748/wjg.v8.i6.1077
Published online Dec 15, 2002. doi: 10.3748/wjg.v8.i6.1077
            Table 1 Statistical analysis of the relevance of expression of sTRAIL and clinical staging of hepatitis B
        
    | n | sTRAIL( × 10-9μg/mL) | |
| HBV carriers | 8 | 876.88 ± 369.59 | 
| Chronic hepatitis | 30 | 1494.97 ± 533.24 | 
| Mild chronic hepatitis | 9 | 1138.90 ± 424.90 | 
| Moderate chronic hepatitis | 12 | 1558.65 ± 489.87a | 
| Severe chronic hepatitis | 9 | 1812.78 ± 499.99b | 
| HBV infectious related cirrhosis | 11 | 1375.00 ± 526.08c | 
| HBV related infectious liver cancer | 3 | 1561.00 ± 449.56d | 
            Table 2 Analysis of corelation between the expression of sTRAIL and clinical indices of hepatitis B
        
    | sTRAIL | Clinical indices | Correlativity coeffficient | ||
| HBV carrier | 876.88 ± 369.59 | ALT | 28.38 ± 5.09 | |
| Tbil | 17.73 ± 3.34 | |||
| ALB | 39.5 ± 1.20 | |||
| Chronic hepatitis | 1494.97 ± 533.24 | ALT | 173.61 ± 135.32 | r = 0.496(P < 0.01) | 
| Tbil | 66.79 ± 61.73 | |||
| ALB | 32.95 ± 5.86 | r = -0.392(P < 0.05) | ||
| HBV infectious related cirrhosis | 1375.00 ± 526.08 | ALT | 150.36 ± 132.72 | |
| Tbil | 82.83 ± 118.00 | |||
| ALB | 34.01 ± 5.79 | |||
| HBV infectious related liver cancer | 1561 ± 449.56 | ALT | 85.67 ± 48.76 | |
| Tbil | 58.81 ± 24.43 | |||
| ALB | 36.63 ± 10.07 | 
            Table 3 Analysis of correlation between the expression of HBsAg and that of sTRAIL
        
    | Group divided by S/N | n | Expression of HBsAg(S/N) | Expression of sTRAIL in peripheral blood ( × 10-9μg/mL) | 
| < 2.1(-) | 2 | 0.5 ± 0.7 | 1852.50 ± 123.74 | 
| > 2.1 and < 10(+) | 0 | ||
| > 10 and < 30(++) | 0 | ||
| > 30 and < 50(+++) | 4 | 43.25 ± 3.78 | 1693.75 ± 547.76 | 
| > 50(++++) | 46 | 61.48 ± 5.19 | 1330.30 ± 537.80 | 
            Table 4 Analysis of the correlation between Expression of HBeAg and that of sTRAIL
        
    | Group divided by S/N | cases | The expression of HBeAg(S/N) | Expression of sTRAIL in peripheral blood ( × 10-9μg/mL) | 
| < 2.1(-) | 14 | 0.86 ± 0.51 | 1166.81 ± 448.84 | 
| > 2.1 and < 10(+) | 9 | 5.47 ± 2.88 | 1088.33 ± 528.27a | 
| > 10 and < 30(++) | 19 | 20.79 ± 5.39 | 1590.26 ± 474.81ab | 
| > 30 and < 50(+++) | 4 | 36.06 ± 4.82 | 1655.00 ± 534.48a | 
| > 50(++++) | 6 | 54.69 ± 4.49 | 1730.83 ± 652.64bc | 
- Citation: Han LH, Sun WS, Ma CH, Zhang LN, Liu SX, Zhang Q, Gao LF, Chen YH. Detection of soluble TRAIL in HBV infected patients and its clinical implications. World J Gastroenterol 2002; 8(6): 1077-1080
- URL: https://www.wjgnet.com/1007-9327/full/v8/i6/1077.htm
- DOI: https://dx.doi.org/10.3748/wjg.v8.i6.1077

 
         
                         
                 
                 
                 
                 
         
                         
                         
                        